agilon health (AGL) “announced the appointment of Tim O’Rourke as Chief Executive Officer and a member of the Company’s Board of Directors, effective May 7. He succeeds Ronald A. Williams, who has served as Executive Chairman since August 2025 and will continue as Chairman of the Board. The appointment comes as agilon enters a new phase following a period of significant operational and financial transformation led by Executive Chairman Ron Williams and the Office of the Executive Chairman. With that work well underway, the Board sought a leader who can build on the Company’s strengthened foundation and capitalize on the long-term demand for physician-led, value-based care.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGL:
- Agilon Health price target raised to $17 from 60c at TD Cowen
- Agilon Health: Limited Upside and Profitability Uncertainty Support Hold Rating
- Agilon Health price target adjusted to $33 from $2 at Deutsche Bank
- Agilon Health price target adjusted to $16 at Evercore ISI after reverse split
- Why Is Vanguard Total Stock Market ETF (VTI) Falling Today, 4/7/2026?
